DocuSign, Inc. (NASDAQ:DOCU – Get Rating) Director Daniel D. Springer sold 147,008 shares of the business’s stock in a transaction dated Thursday, January 19th. The shares were sold at an average price of $55.08, for a total value of $8,097,200.64. Following the sale, the director now owns 1,225,714 shares in the company, valued at approximately $67,512,327.12. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
DocuSign Price Performance
Shares of DocuSign stock opened at $58.69 on Tuesday. The business has a 50 day simple moving average of $52.30 and a two-hundred day simple moving average of $55.55. DocuSign, Inc. has a 12 month low of $39.57 and a 12 month high of $131.91. The stock has a market capitalization of $11.80 billion, a P/E ratio of -88.92 and a beta of 1.00. The company has a debt-to-equity ratio of 1.46, a current ratio of 1.02 and a quick ratio of 1.02.
DocuSign (NASDAQ:DOCU – Get Rating) last announced its earnings results on Thursday, December 8th. The company reported $0.05 EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.13. DocuSign had a negative return on equity of 18.86% and a negative net margin of 5.45%. The business had revenue of $645.46 million during the quarter, compared to analysts’ expectations of $626.07 million. As a group, analysts predict that DocuSign, Inc. will post -0.1 EPS for the current fiscal year.
Hedge Funds Weigh In On DocuSign
Analyst Upgrades and Downgrades
A number of analysts have recently commented on DOCU shares. Morgan Stanley downgraded DocuSign from an “overweight” rating to an “equal weight” rating and lowered their target price for the stock from $73.00 to $47.00 in a research note on Monday, October 3rd. Royal Bank of Canada lowered their target price on DocuSign from $65.00 to $55.00 in a research note on Thursday, September 29th. Citigroup upped their target price on DocuSign from $59.00 to $72.00 and gave the stock a “buy” rating in a research note on Monday, December 12th. Wedbush upgraded DocuSign from an “underperform” rating to a “neutral” rating and set a $55.00 target price on the stock in a research note on Wednesday, October 12th. Finally, Robert W. Baird lowered their target price on DocuSign from $70.00 to $50.00 and set a “neutral” rating on the stock in a research note on Monday, December 5th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $59.71.
DocuSign, Inc provides electronic signature software in the United States and internationally. The company provides e-signature solution that enables businesses to digitally prepare, sign, act on, and manage agreements. It also offers CLM, which automates workflows across the entire agreement process; Insights that use artificial intelligence (AI) to search and analyze agreements by legal concepts and clauses; Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce; Negotiate for Salesforce that supports for approvals, document comparisons, and version control; Analyzer, which helps customers understand what they're signing before they sign it; and CLM+ that provide AI-driven contract lifecycle management.
- Get a free copy of the StockNews.com research report on DocuSign (DOCU)
- Is the Northrop Grumman Selloff an Opportunity?
- Is the Worst Behind for Under Armor Stock with a New CEO?
- What Does Microsoft’s Investment in ChatGBT Mean for MSFT Stock?
- Analysts Like The Fit Of Skechers USA
- Can We Trust The Rally In The S&P 500
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.